Loading…
Loading…
NEW YORK, July 01, 2026 (GLOBE NEWSWIRE) -- High Income Securities Fund (NYSE: PCF) (the “Fund”) today announced that the Fund's Board of Trustees (the “Board”) has declared the next three monthly distributions under the Fund's managed distribution plan.
LOS ANGELES--(BUSINESS WIRE)--The Prostate Cancer Foundation (PCF) and the BIG3, the professional 3-on-3 basketball league co-founded by Ice Cube, today announced a new partnership to advance PCF's “Check the Box! Saving Lives Together” initiative — a nationwide campaign encouraging every man, particularly Black men, gets screened for prostate cancer with a simple PSA blood test. Prostate cancer is diagnosed at a rate of roughly one new case every 90 seconds in the United States — and claims a.
Celanese Corporation (NYSE: CE), a global specialty materials and chemical company, today announced that Aisan Industry Kentucky, LLC., the consolidated subsid
High Income Securities Fund is downgraded to a sell due to persistent NAV erosion and unsustainable distributions. PCF trades at a 12.63% discount to NAV, but this reflects ongoing earnings and dividend sustainability challenges. Net investment income remains insufficient to cover the 12.1% yield, with payouts exceeding earnings and accelerating capital erosion.
NEW YORK, April 13, 2026 (GLOBE NEWSWIRE) -- High Income Securities Fund (NYSE: PCF) (the “Fund”) today announced that the Fund's Board of Trustees (the “Board”) has declared the next three monthly distributions under the Fund's managed distribution plan.
Lumen's NaaS and PCF deals, fiber expansion and AI-driven network demand are fueling growth, with billions in deals and rising enterprise adoption.
The High Income Securities Fund offers deep diversification via a sleeve of fund-of-funds exposure, currently trading at a -11.50% discount to NAV. PCF's expense ratio is fairly high, which is compounded by underlying CEF and BDC fees, but the fund's discount-on-discount structure creates tactical appeal. The managed 10% distribution policy has led to payout reductions over time, but with the current yield at 11.43%, propped up by its discount.
Samsung Biologics' PCF system validated in line with globally established ISO and PAS standards Validation reflects continued efforts to establish credible carbon accounting in support of net-zero goals Validated system provides reliable, consistent carbon footprint data for clients INCHEON, South Korea, Feb. 6, 2026 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS), a leading contract development and manufacturing organization (CDMO), announced that its product carbon footprint (PCF) system has been validated by Det Norske Veritas (DNV), an independent third-party assurance provider, confirming alignment with globally recognized standards. The validation confirms that Samsung Biologics' PCF calculation methodology complies with global standards, including ISO 14067 and PAS 2050.
Full call transcripts — prepared remarks + analyst Q&A — with speaker-by-speaker formatting and one-click switching across every quarter on file.
Click below to see what's inside, then upgrade to read every transcript for PCF and 80,000+ other tickers.
Transcripts source: company-published earnings calls. Speaker attribution and formatting are processed in-app.